Headache clinical trials

Explore recruiting headache clinical trials.

Recruiting headache studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Headache trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

SUNCET: Low sodium oxybate Use for Nocturnal Cluster headache: safety, Efficacy and Tolerability of XYWAV - a Phase 2 Randomized, Double-Blind, Placebo-Controlled, bi-center Study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

A Randomized, Double-blind, Parallel-group, Active Controlled Trial with Open-label Safety Extension to Evaluate the Tolerability, Safety, and Efficacy of Atogepant versus Topiramate in Subjects Requiring Preventive Treatment of Migraine (TEMPLE)

Belgium, Austria, Poland, Czechia, Italy, Germany +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase 3 randomized, placebo-controlled, triple blind parallel-group study of candesartan in adults with episodic cluster headache (Episodic CandClus2)

Denmark, Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

Calcium Channel blocker in treatment of reversible cerebral vasoconstriction syndrome: a double-blind, randomized, placebo-controlled trial.

Finland

Therapeutic use (Phase IV) EU CTIS Study details

Efficacy and safety of minidosing lysergic acid diethylamide (LSD) for chronic cluster headache: a randomized placebo-controlled study

Netherlands

Therapeutic exploratory (Phase II) EU CTIS Study details

C4951004 - BHV3000-406: A Phase 4, Randomized, Double-blind Placebo Controlled, Efficacy and Tolerability Trial of Rimegepant for the Acute Treatment of Migraine in Adults Unsuitable for Triptan Use

Finland, Germany, Sweden, Austria, Belgium, France +4 more

Therapeutic use (Phase IV) EU CTIS Study details

Headache trials by city

Headache in Toronto Headache in Vancouver Headache in Montreal Headache in Calgary Headache in Edmonton Headache in Ottawa Headache in Winnipeg Headache in Quebec City Headache in Hamilton Headache in Kitchener Headache in London Headache in Halifax Headache in New York Headache in Los Angeles Headache in Chicago Headache in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease